First In Human, antibody drug conjugate, cancer, solid tumour, Phase I
Showing 1 - 25 of >10,000
Neuroendocrine Carcinomas, Neuroendocrine Tumors, Carcinoma, Neuroendocrine Trial run by the National Cancer Institute (NCI)
Not yet recruiting
- Neuroendocrine Carcinomas
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Sep 22, 2023
Relapsed Solid Tumor, Refractory Cancer, Solid Tumor, Adult Trial (STI-3258)
Withdrawn
- Relapsed Solid Neoplasm
- +2 more
- STI-3258
- (no location specified)
Jan 24, 2023
Cancer Trial (Antibody-Drug Conjugate)
Not yet recruiting
- Cancer
- Antibody-Drug Conjugate
- (no location specified)
Aug 23, 2023
Solid Tumor Trial in Belgium, Netherlands, United Kingdom (SYD985 + Niraparib)
Active, not recruiting
- Solid Tumor
- SYD985 + Niraparib
-
Antwerp, Belgium
- +5 more
Jan 23, 2023
Advanced Solid Tumors Trial in Guangzhou (BAT8007 for injection)
Recruiting
- Advanced Solid Tumors
- BAT8007 for injection
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
May 26, 2023
Solid Tumor Trial in United States (TR1801-ADC)
Active, not recruiting
- Unspecified Adult Solid Tumor, Protocol Specific
- TR1801-ADC
-
Los Angeles, California
- +4 more
Oct 30, 2022
Advanced Solid Tumors Trial in Canada, United States (LCB84, Anti-PD-1 mAb)
Not yet recruiting
- Advanced Solid Tumors
- LCB84
- Anti-PD-1 monoclonal antibody
-
Los Angeles, California
- +6 more
Jul 4, 2023
Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer Trial in Australia (IKS014)
Not yet recruiting
- Breast Cancer
- +2 more
-
Concord, New South Wales, Australia
- +4 more
May 30, 2023
Locally Advanced/Metastatic Solid Tumors Trial in Newport Beach, San Diego, Canton (FL115)
Active, not recruiting
- Locally Advanced/Metastatic Solid Tumors
-
Newport Beach, California
- +2 more
Nov 10, 2023
Advanced Solid Tumours, Carcinoma Non-small Cell Lung, Head and Neck Tumors Trial in Worldwide (AZD9592, Osimertinib)
Recruiting
- Advanced Solid Tumours
- +2 more
-
Duarte, California
- +13 more
Jan 5, 2023
Cancer, Tumor, Solid, Advanced Solid Tumor Trial in Houston (NTX-1088, Pembrolizumab)
Recruiting
- Cancer
- +4 more
-
Houston, TexasThe University of Texas MD Anderson Cancer Center
Jan 24, 2023
Advanced or Metastatic Solid Tumors Trial in Toulouse, Villejuif, Barcelona (W0101 - Cohort A1, W0101 - Cohort A2, W0101 -
Active, not recruiting
- Advanced or Metastatic Solid Tumors
- W0101 - Cohort A1
- +2 more
-
Toulouse, France
- +2 more
Dec 19, 2022
Human Cancers Trial in Cambridge, London (MOv18 IgE)
Completed
- Human Cancers
- MOv18 IgE
-
Cambridge, United Kingdom
- +2 more
May 19, 2022
Advanced Ovarian Carcinoma, Advanced Renal Cell Carcinoma, Advanced Pancreatic Carcinoma Trial in Bydgoszcz, Otwock, Warsaw
Recruiting
- Advanced Ovarian Carcinoma
- +7 more
-
Bydgoszcz, Kujawsko-pomorskie, Poland
- +2 more
Mar 7, 2023
Advanced Solid Tumors Trial in Beijing, Shanghai (JS108 (recombinant humanized anti-Trop2 mAb-Tub196 conjugate for injection))
Recruiting
- Advanced Solid Tumors
- JS108 (recombinant humanized anti-Trop2 mAb-Tub196 conjugate for injection)
-
Beijing, Beijing, China
- +2 more
Apr 1, 2022